Gene-based therapies for restenosis

[1]  D. Dichek,et al.  Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors. , 1996, Circulation.

[2]  H. Blau,et al.  Muscle-mediated gene therapy. , 1995, The New England journal of medicine.

[3]  C. Guérot,et al.  Which gene for which restenosis? , 1995, The Lancet.

[4]  B. Davidson,et al.  Adenovirus-mediated gene transfer to normal and atherosclerotic arteries. A novel approach. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[5]  H. W. Sharma,et al.  The therapeutic potential of antisense oligonucleotides. , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[6]  G. Noll,et al.  [Molecular medicine and gene therapy as exemplified with arteriosclerosis and restenosis]. , 1995, Schweizerische medizinische Wochenschrift.

[7]  J. Leiden,et al.  Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. , 1995, The Journal of clinical investigation.

[8]  X. Breakefield,et al.  Gene Therapy for Brain Tumors , 1995, Brain pathology.

[9]  F. Ledley.  Nonviral gene therapy: the promise of genes as pharmaceutical products. , 1995, Human gene therapy.

[10]  A. Harken,et al.  Potential gene therapy strategies in the treatment of cardiovascular disease. , 1995, The Annals of thoracic surgery.

[11]  J. Isner,et al.  Gene therapy for the vulnerable plaque. , 1995, Journal of the American College of Cardiology.

[12]  E. Marshall.  Gene therapy's growing pains , 1995, Science.

[13]  Stewart Fm.  Getting human gene therapy to work. , 1995 .

[14]  P. Libby,et al.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.

[15]  B. Davidson,et al.  Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. , 1995, Circulation research.

[16]  S. Epstein,et al.  Gene therapy for vascular disease , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  T. Ogihara,et al.  A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Jason A. Lowry,et al.  Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. , 1995, Circulation.

[19]  B. Sobel,et al.  Vascular smooth muscle cell migration mediated by thrombin and urokinase receptor. , 1995, The American journal of physiology.

[20]  E. Topol,et al.  Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury. , 1995, Circulation research.

[21]  J. Wilcox,et al.  Thrombotic mechanisms in atherosclerosis: potential impact of soy proteins. , 1995, The Journal of nutrition.

[22]  M. Runge,et al.  Role of the thrombin receptor in restenosis and atherosclerosis. , 1995, The American journal of cardiology.

[23]  Y. Kaneda,et al.  Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Nikol,et al.  Enhanced Migratory Activity of Vascular Smooth Muscle Cells with High Expression of Platelet-Derived Growth Factor A and B , 1995, Angiology.

[25]  E. Edelman,et al.  c-myc in vasculoproliferative disease. , 1995, Circulation research.

[26]  J. Seltzer,et al.  Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product , 1995, Science.

[27]  E. Nabel,et al.  Gene therapy for cardiovascular disease. , 1995, Circulation.

[28]  T. Ogihara,et al.  Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery. , 1994, Gene.

[29]  A. Zalewski,et al.  Transgene expression in the coronary circulation: transcatheter gene delivery. , 1994, Gene therapy.

[30]  B. A. French,et al.  Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. , 1994, Circulation.

[31]  D. Muller.  Gene therapy for cardiovascular disease. , 1994, British heart journal.

[32]  M. Perricaudet,et al.  Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. , 1994, Circulation.

[33]  M. Rekhter,et al.  Cell proliferation and collagen synthesis are two independent events in human atherosclerotic plaques. , 1994, Journal of vascular research.

[34]  E. Nabel,et al.  Gene therapy for vascular smooth muscle cell proliferation after arterial injury. , 1994, Science.

[35]  Atsushi Namiki,et al.  Indirect Angiogenic Cytokines Upregulate VEGF and bFGF Gene Expression in Vascular Smooth Muscle Cells, Whereas Hypoxia Upregulates VEGF Expression Only , 1994 .

[36]  G. R. Dodge,et al.  Transcatheter Delivery of c‐myc Antisense Oligomers Reduces Neointimal Formation in a Porcine Model of Coronary Artery Balloon Injury , 1994, Circulation.

[37]  E. Edelman,et al.  Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model. , 1994, The Journal of clinical investigation.

[38]  S. Epstein,et al.  The basis of molecular strategies for treating coronary restenosis after angioplasty. , 1994, Journal of the American College of Cardiology.

[39]  E. Nabel,et al.  Gene transfer and vascular disease. , 1994, Cardiovascular research.

[40]  G. Evan,et al.  Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. , 1994, The Journal of clinical investigation.

[41]  P. Libby,et al.  Enhanced Expression of Vascular Matrix Metalloproteinases Induced In Vitro by Cytokines and in Regions of Human Atherosclerotic Lesions a , 1994, Annals of the New York Academy of Sciences.

[42]  P. Libby,et al.  Cytokines Regulate Genes Involved in Atherogenesis a , 1994, Annals of the New York Academy of Sciences.

[43]  R. Crystal,et al.  Efficient and Selective Adenovirus‐Mediated Gene Transfer Into Vascular Neointima , 1993, Circulation.

[44]  R. Derynck,et al.  Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Wilcox,et al.  Molecular biology: insight into the causes and prevention of restenosis after arterial intervention. , 1993, The American journal of cardiology.

[46]  M. Reidy,et al.  Basic fibroblast growth factor: its role in the control of smooth muscle cell migration. , 1993, The American journal of pathology.

[47]  T. Finkel,et al.  Do antisense approaches to the problem of restenosis make sense? , 1993, Circulation.

[48]  H. Anderson.  Restenosis after coronary angioplasty. , 1993, Disease-a-month : DM.

[49]  D. Hall,et al.  Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells. , 1993, Circulation.

[50]  R. Wilensky,et al.  Methods and devices for local drug delivery in coronary and peripheral arteries. , 1993, Trends in cardiovascular medicine.

[51]  R. Ross,et al.  Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[52]  E. Nabel,et al.  Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo , 1993, Nature.

[53]  C. Haudenschild,et al.  Pathobiology of restenosis after angioplasty. , 1993, The American journal of medicine.

[54]  E. Nabel,et al.  Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo. , 1993, The Journal of clinical investigation.

[55]  H. Lundqvist,et al.  Pathophysiological mechanisms for restenosis following coronary angioplasty: possible preventive alternatives , 1993, Journal of internal medicine.

[56]  E. Nabel,et al.  Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. , 1992, Human gene therapy.

[57]  J. Marmur,et al.  Induction of PDGF-responsive genes in vascular smooth muscle. Implications for the early response to vessel injury. , 1992, Circulation.

[58]  D. Gordon.  Cell proliferation in human arteries. , 1992, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[59]  J. Isner,et al.  Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. , 1992, The Journal of clinical investigation.

[60]  Michael Simons,et al.  Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo , 1992, Nature.

[61]  Ward Casscells,et al.  Migration of Smooth Muscle and Endothelial Cells: Critical Events in Restenosis , 1992, Circulation.

[62]  T. Flotte,et al.  Gene expression from adeno-associated virus vectors in airway epithelial cells. , 1992, American journal of respiratory cell and molecular biology.

[63]  S. Epstein,et al.  Inhibition of Smooth Muscle Cell Proliferation by an Antisense Oligodeoxynucleotide Targeting the Messenger RNA Encoding Proliferating Cell Nuclear Antigen , 1992, Circulation.

[64]  E. Nabel.  Direct gene transfer into the arterial wall. , 1992, Journal of vascular surgery.

[65]  K. Newman,et al.  Low Level In Vivo Gene Transfer Into the Arterial Wall Through a Perforated Balloon Catheter , 1992, Circulation.

[66]  J. Wilcox.  Thrombin and other potential mechanisms underlying restenosis. , 1991, Circulation.

[67]  V. Fuster,et al.  The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. , 1991, Journal of the American College of Cardiology.

[68]  E. Nabel,et al.  Introduction of vascular smooth muscle cells expressing recombinant genes in vivo. , 1991, Circulation.

[69]  D. Dichek,et al.  Enhancement of the fibrinolytic activity of sheep endothelial cells by retroviral vector-mediated gene transfer. , 1991, Blood.

[70]  E. Nabel,et al.  Site-specific gene expression in vivo by direct gene transfer into the arterial wall. , 1990, Science.

[71]  V. Fuster,et al.  Interactions of Platelets and Vessel Wall in the Development of Restenosis after Coronary Angioplasty a , 1987, Annals of the New York Academy of Sciences.

[72]  V. Fuster,et al.  Restenosis after arterial angioplasty: a hemorrheologic response to injury. , 1987, The American journal of cardiology.

[73]  L. Harker,et al.  Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. , 1987, The American journal of cardiology.

[74]  T. Flotte,et al.  An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. , 1995, Gene therapy.

[75]  B. Trapnell,et al.  Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy. , 1995, Human gene therapy.

[76]  S. Pang,et al.  Gene therapy: principles and potential. , 1995, Cancer surveys.

[77]  B. A. French,et al.  Coronary restenosis and gene therapy. , 1994, Texas Heart Institute journal.

[78]  T. Ogihara,et al.  Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy. , 1993, Transactions of the Association of American Physicians.

[79]  K. Newman,et al.  A genetic therapy for familial hypercholesterolemia. , 1990, Transactions of the Association of American Physicians.

[80]  V. Fuster,et al.  Platelet-vessel wall interactions in the development of restenosis after coronary angioplasty. , 1987, Zeitschrift fur Kardiologie.

[81]  P C Adams,et al.  Role of platelets in atherogenesis: relevance to coronary arterial restenosis after angioplasty. , 1987, Cardiovascular clinics.